HOME >> BIOLOGY >> NEWS
Scientists discover that metastases share a similar genetic profile to their primary tumour

Hamburg, Germany: Work by scientists in The Netherlands has contradicted the notion that breast cancer metastases behave differently to their primary tumours.

PhD student, Britta Weigelt told the meeting of the 4th European Breast Cancer Conference today (Thursday 18 March) that, contrary to what had been thought previously, any primary breast cancer cell was capable of producing secondary cancer cells, which then spread to other parts of the body. These secondary cancer cells had a strikingly similar genetic make-up to their parent cells and behaved in a similar way. Therefore, metastases were likely to have the same response to a particular treatment as their primary tumour.

The discovery has implications for the treatment of breast cancer once researchers have identified the ways that genetically different tumours respond to a variety of therapies. Based on the genetic profile of a patient's tumour, doctors could choose the best treatment for that particular type of tumour (from specific types of chemo-, radio- or hormonal therapies) and treat the patient with it from the time of diagnosis. Such early (neo-adjuvant) treatment could not only shrink the primary tumour but might also prevent the outgrowth of micrometastases, thereby saving lives, as metastases that occur in other parts of the body are notoriously difficult to treat successfully and are the main cause of death in breast cancer.

Mrs Weigelt said: "Until now it was largely unknown whether the characteristics of breast cancer that define the growth rate and therapy response of the primary tumour were alike in the metastases. Furthermore, it was unclear whether all primary breast cancer cells were capable of metastasising, or only some of them."

In the first study to do this, Mrs Weigelt and her colleagues at the Netherlands Cancer Institute in Amsterdam compared the activities of genes in samples of primary breast tumours from 15 patients and in their matching lymph
'"/>

Contact: Emma Mason
wordmason@aol.com
49-403-569-3625
Federation of European Cancer Societies
18-Mar-2004


Page: 1 2

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
Breaking Biology Technology:
Cached News: